Regarding cancer metastasis, a recent study reported that MEF2C was consistently expressed in breast cancer brain metastases, and that its nuclear translocation was related to brain metastatic disease severity via VEGFR-2 and β-catenin signaling [46]. Here, MEF2C is linked to cancer.